Modeling Diet-Induced Obesity with Obesity-Prone Rats: Implications for Studies in Females by Erin D. Giles et al.
November 2016 | Volume 3 | Article 501
Review
published: 24 November 2016
doi: 10.3389/fnut.2016.00050
Frontiers in Nutrition | www.frontiersin.org
Edited by: 








Erin D. Giles 
egiles@tamu.edu; 
Paul S. MacLean 
paul.maclean@ucdenver.edu
Specialty section: 
This article was submitted 
to Clinical Nutrition, 






Giles ED, Jackman MR and 
MacLean PS (2016) Modeling 
Diet-Induced Obesity with  
Obesity-Prone Rats: Implications 
for Studies in Females. 
Front. Nutr. 3:50. 
doi: 10.3389/fnut.2016.00050
Modeling Diet-induced Obesity 
with Obesity-Prone Rats: 
implications for Studies in Females
Erin D. Giles1*, Matthew R. Jackman2,3 and Paul S. MacLean2,3*
1 Department of Nutrition and Food Science, Texas A&M University, College Station, TX, USA, 2 Anschutz Health and 
Wellness Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA, 3 Division of Endocrinology, Diabetes 
and Metabolism, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Obesity is a worldwide epidemic, and the comorbidities associated with obesity are 
numerous. Over the last two decades, we and others have employed an outbred rat 
model to study the development and persistence of obesity, as well as the metabolic 
complications that accompany excess weight. In this review, we summarize the strengths 
and limitations of this model and how it has been applied to further our understanding of 
human physiology in the context of weight loss and weight regain. We also discuss how 
the approach has been adapted over time for studies in females and female-specific 
physiological conditions, such as menopause and breast cancer. As excess weight 
and the accompanying metabolic complications have become common place in our 
society, we expect that this model will continue to provide a valuable translational tool 
to establish physiologically relevant connections to the basic science studies of obesity 
and body weight regulation.
Keywords: obesity resistance, weight regain, menopause, breast cancer, exercise, adipose, high-fat diet, 
sex differences
iNTRODUCTiON
Worldwide obesity rates have more than doubled since the 1980s, and in 2014 more than 39% of 
adults were overweight, and 13% were obese (1). This translates to an estimated 1.9 billion adults 
who are overweight, of whom more than 600 million are obese. Further, 41 million children under 
the age of 5 are also overweight or obese, making obesity a worldwide epidemic. While obesity was 
once only a problem for high-income countries, there are now more deaths worldwide attributed 
to overweight and obesity than underweight. Obesity negativity affects virtually every system of the 
body and increases the risk for cardiovascular disease, diabetes, osteoarthritis, and many cancers. 
While childhood obesity increases the risk of obesity in adulthood, it also poses immediate risks to 
children, such as breathing difficulties, increased risk of fractures, and psychological effects. Further, 
markers of metabolic disease that were once considered limited to adults are now appearing in 
children with obesity, including hypertension, insulin resistance, and early markers of cardiovascular 
disease. Clearly our current efforts to stop this growing epidemic are not working, and there is an 
urgent need to understand the etiology and to develop new strategies, interventions, and therapies 
to prevent and/or treat this disease.
It is generally accepted that the problem of obesity reflects the merger of environmental, 
biological, and psychosocial pressures (2). Underlying the biological component of this issue is 
the genetic and epigenetic foundation that establishes the systems controlling energy homeostasis 
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and body weight regulation. The heterogeneity of this founda-
tion imparts variability in how these systems function and 
respond to external challenges and stressors. Even in the cur-
rent obesogenic environment, not all individuals become obese. 
While some individuals have a predisposition to accumulate 
excess weight, others have a predisposition to remain lean. 
For the vast majority of the population, the variability in the 
predisposition for obesity is not linked to a single mutation 
or epigenetic insult. Rather, numerous genes and epigenetic 
events are involved in generating a polygenic predisposition 
that favors leanness, obesity, or some level of adiposity between 
the two extremes, when faced with obesogenic environmental 
pressures.
One environmental pressure believed to be promoting obesity 
is the availability of energy dense diets. In animal models, this 
has been shown to increase energy intake (3–6) and eventually 
leads to the development of obesity and insulin resistance (7–10). 
However, the susceptibility to obesity in response to this chal-
lenge is highly dependent upon the strain of the animal (11–18). 
The purpose of this review is to summarize the development, 
nuances, and applications of an approach that models this poly-
genic susceptibility to the development of obesity in response to 
the common environmental pressure of a freely available energy 
dense diet. This experimental paradigm has been, and continues 
to be, a valuable tool to translate the wealth of knowledge from 
basic science studies of energy balance to physiological relevant 
aspects of the human condition.
DieT-iNDUCeD OBeSiTY (DiO) FROM  
OBeSiTY-PRONe ANiMALS
DiO in the Context of Alternative 
Models of Obesity
Numerous types of animal models have been employed to 
study obesity. Certain mutations, as with leptin or the leptin 
receptor, give rise to monogenic forms of obesity with extreme 
phenotypes (19). These models have proven very valuable in 
elucidating the function of specific factors involved in energy 
homeostasis and body weight regulation. It has become clear, 
however, that the biological contribution to obesity in humans 
involves numerous factors in a number of tissues that coordi-
nately favor the accumulation and maintenance of an excess 
amount of adiposity. Translating these observations to the 
human condition requires applying this information in a more 
physiologically relevant context.
As an alternative, different strains of animals with a known 
genetic disposition for leanness or obesity have been studied. 
The Osborne–Mendel (OM) and S5B/P1 model is one such 
example. In studies comparing several strains of rats on a high 
fat (HF) diet, OM rats were identified as prone to the develop-
ment of obesity, while S5B/P1 rats were resistant (8). Using such 
models has helped researchers identify genetic differences that 
contribute to the predisposition to develop obesity. However, 
the heterogeneity between these two strains also imposes 
unwanted variability in comparative studies that may be irrel-
evant or confounding.
To overcome the potential confound of strain differences, 
we and others have utilized an approach that yields a range of 
adiposity phenotypes within the same strain. Because a diet high 
in fat has been linked to obesity in both humans and animal 
models, this has become the most common challenge used to 
select the extremes of adiposity phenotypes. The strengths of 
this approach are that the polygenic predisposition for obesity 
reflects a differential response to the diet, while minimizing the 
extraneous differences between strains. This general approach 
has been used with both inbred and outbred strains of rats 
and mice to select those that become lean or obese with the 
same dietary challenge. Selection from inbred strains, which 
are considered to be isogenic, provides a more modest range 
of phenotypes that presupposes less genetic variability and 
emphasizes epigenetic variability in driving the phenotype. In 
contrast, selection from outbred strains presupposes greater 
variability in both genetic and epigenetic differences, which 
likely better reflects the susceptibility to obesity in humans. The 
diet-induced obesity (DIO)/diet-resistant (DR) model of obesity 
that we emphasize in the discussion of this review are derived 
from outbred rats (15, 18).
Over the past two decades, some confusion has emerged in the 
terminology used in describing outbred models. We and others 
have often referred to them as obesity-prone (OP) and obesity-
resistant (OR), rather than DIO and DR. The two different nam-
ing schemes have often been used interchangeably, while others 
have inferred some distinction between them. Here, we propose 
that both classifications have value and are inherently related, in 
that the polygenic predisposition (OP/OR) ultimately leads to 
the respective phenotype (DIO/DR), when challenged with the 
obesogenic selection diet. To minimize the confusion in future 
studies, we propose the following definitions that distinguish the 
use of these terms:
•	 OP: a person or animal that has a predisposition to become 
obese when challenged with an obesogenic environmental 
pressure;
•	 OR: a person or animal that has a predisposition to remain 
lean when challenged with the same obesogenic environment;
•	 DIO: the OP person or animal that has become obese in 
response to the obesogenic diet; and
•	 DR: the OR person or animal that has remained lean in 
response to the obesogenic diet.
evolution of the Selection  
Process – A Historical Perspective
Selection and study of OP/OR phenotypes began over 25 years 
ago in both Sprague-Dawley and Wistar outbred rats (18, 20). In 
general, a relatively large group of outbred rats was challenged 
with a HF diet for a defined period of time, and the cohort was 
stratified by the amount of weight gained. For the early studies 
from Hill et al. (21, 22), Wistar rats were obtained from Harlan 
Laboratories (Madison, WI, USA; now Envigo). The low fat 
(LF) acclimation diet consisted of a 20% LF diet (20% kcal from 
fat; 20% protein; 60% carbohydrate) for 2  weeks. A 60% HF 
diet (60% kcal from fat; 20% protein; 20% carbohydrate) was 
then fed for 4–5 weeks, and the top and bottom 25% of weight 
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gainers were identified as either OP or OR. At the end of the 
10-week study, body composition and fat pad weights con-
firmed the DIO and DR phenotypes. Subsequent modifications 
to the protocol selected the top and bottom tertiles (rather than 
quartiles) to represent the extremes of weight gain (23). During 
a similar time period, Levin published similar findings using a 
different strain and a different obesity-inducing diet. In these 
studies, male Sprague-Dawley rats were fed a diet consisting 
of chow, corn oil, and sweetened condensed milk [~31% kcal 
fat and 45–53%  kcal carbohydrate (primarily sucrose)]. Like 
the Wistar rats, only about half of the rats consuming this diet 
for 3–5  months gained excess weight compared to chow-fed 
controls (20, 24–26).
Over the years, there have been a number of different modi-
fications to the design of the selection diet that are particularly 
relevant to note. Levin’s group has consistently employed a diet 
that contains sucrose, in addition to being high in fat. In some 
studies, Levin’s group also used the highly palatable liquid diet 
Ensure (27, 28). In contrast, Hill’s research team moved to LF 
and HF diets with 12 and 45%  kcal from fat, with the protein 
component held constant at 20%. Further, the sucrose component 
of the original HF diet was replaced with starch (29). Finally, in 
conjunction with a move to the University of Colorado in 1997, 
Charles River Laboratories (Wilmington, MA, USA) became the 
source for Wistar rats, while maintaining the 12 and 45% fat for 
the LF and HF diets, respectively (14).
In 1994, Pagliassotti et  al. modified the selection protocol 
to demonstrate that weight gain during the first week on the 
HF diet was highly predictive of weight gain over the four sub-
sequent weeks. Specifically, they reported a strong correlation 
between weight gain after 1 and 5 weeks of HF feeding (r = 0.87; 
n = 200) (12). Based on this finding, most subsequent studies 
have relied on this shorter duration of HF diet screening for 
identifying OP and OR rats. In collaboration with Hill’s group, 
a study out of the Leibowitz lab (30) used a similar model 
in Sprague-Dawley rats to identify measures in prepubertal 
animals that were predictive of adult adiposity. Similar to 
studies in Wistar rats from the Hill lab, they found that weight 
gain across a 5-day interval from 30 to 35 days of age on a HF 
diet (45–60%  kcal fat) was strongly and positively correlated 
(r2 = 0.71–0.82) with accumulated body fat in four depots after 
4–6  weeks of HF feeding. Screening in younger animals did 
not show this same correlation, suggesting that waiting until 
4–5 weeks of age is necessary to identify OP and OR phenotypes 
using this model (30). Similarly, Levin’s group have also shown 
that the DIO and DR phenotypes are not different between 3 
and 5 weeks of age (31).
Overall, the diet and the timeframe of selection has evolved 
and varied between groups over the past 25  years. A reduced 
time frame for selection allows for animals to be studied earlier 
in the development of the DIO/DR phenotypes. Diet composi-
tion has evolved to better reflect a more reasonable and relevant 
amount of fat (40–50% kcal), and either to include or not include 
sucrose as a portion of the carbohydrate component. It should 
be noted that the addition of sucrose can lead to more severe 
metabolic derangements in the DIO animals that are generated, 
even to the extent of developing diabetes in some cases.
Levin’s DiO/DR Model – Selective 
inbreeding
One limitation of a model that requires stratification based on 
weight gain is that differences between OP and OR phenotypes 
cannot be studied prior to the dietary challenge. To circumvent 
this limitation, Levin et  al. developed inbred lines of DIO and 
DR rats that were derived from OP and OR Sprague-Dawley rats. 
Briefly, outbred Sprague-Dawley rats that were either susceptible 
or resistant to weight gain after 2 weeks on a HF, high energy diet 
were identified and inbred (15). After five generations of selective 
inbreeding, the resultant lines breed true to their respective phe-
notypes, with a bimodal distribution of weight gain in response to 
the high energy diet. The resulting lines of animals were termed 
DIO or DR for those that were either susceptible or resistant to 
DIO, respectively. These valuable lines have provided the means 
to examine preexisting differences between OP and OR animals, 
as well as the differential responses that occur within the first few 
days of exposure to a HF and/or high energy diet.
Current Selection Protocol for DiO/DR 
Studies of Obesity
In recent years, we have employed a standardized dietary screen 
of outbred rats (Figure 1) to identify those rats that have a poly-
genic predisposition for resistance or propensity to become obese 
under environmental pressures that are thought to contribute to 
obesity in humans: consumption of a HF diet and limited physical 
activity (18, 32–35). While we typically use Wistar rats, outbred 
Sprague-Dawley rats have also been used with success. A number 
of vendors are available that commercially produce semi-purified 
diets, but we have typically used Research Diets D12344 and 
D11724 as our HF (46%) and LF (12%) diets, respectively.
As a general protocol, rats arrive at our facility at ~5 weeks 
of age. They are individually housed in wire bottom cages and 
provided free access to a LF diet for an acclimation period of 
~2 weeks. This allows time for any institution-required quaran-
tine, recovery from the stress of transport, and an opportunity to 
perform any baseline measurements. Following acclimation, rats 
are provided ad libitum access to the HF diet, which results in a 
heterogeneous distribution of body weight gain in the outbred 
animals. Rats have traditionally been ranked according to their 
change in body weight in response to HF feeding; those with the 
lowest weight gain are classified as OR, whereas those with the 
greatest weight gain are classified as OP. At this point, animals in 
the middle group are removed from the study. The HF diet is a 
critical component for the separation of rats into the OP and OR 
phenotypes as there is no difference in body weight gain when the 
animals are consuming an LF diet.
In addition to feeding a HF diet, another key requirement 
for emergence of the OP and OR phenotypes in this model is 
individual housing in wire bottom cages. Individual housing 
serves several purposes. First, it limits the physical activity of 
the animals compared to animals housed in a group environ-
ment (36), as group-housed animals are constantly engaged 
with one another. Second, it allows for more precise measures 
of food intake, which is often an outcome in studies of this 
nature. Third, it prevents dominant animals from influencing 
FigURe 1 | general screening procedure for selecting OP and OR rats. Outbred Wistar rats that arrive at ~5 weeks of age are placed in individual wire 
bottom cages that limit physical activity and allow for accurate measurement of food intake and spill. Food intake, body weight, and body composition are 
monitored for the duration of the study. Following a brief acclimation period, rats are provided ad libitum access to the HF diet, which results in a heterogeneous 
distribution of body weight gain in the outbred animals. Obesity-prone (OP) and -resistant (OR) animals are identified as described in the text and matured into 
diet-induced obese (DIO) and diet-resistant (DR) animals, respectively.
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food intake patterns of other rats in the group (37). Finally, it 
prevents coprophagia that can be common in studies of energy 
restriction and weight loss. In most of our studies, we use rat 
cages measuring ~9.25″(L) × 6.75″(W) × 6.75″(H), although we 
have also used slightly larger cages with success.
Developing the DiO/DR Model 
for Studies in Females
Sex-specific effects and sex differences in outcomes have received 
greater attention over the last decade as the scientific community 
has developed an appreciation for the importance of the biologi-
cal variable of sex. Barry Levin’s inbred DIO/DR lines have been 
valuable in this regard, as females could be derived directly from 
the respective inbred lines. The use of outbred strains presented 
a challenge with the selection of OP and OR rats, in that the 
unique aspects of female physiology and the associated vari-
ability confounded the screening process. Even so, the expense 
of maintaining Levin’s inbred lines and the tenuous nature of 
their commercial availability led us to develop a more consistent 
screening protocol for the more readily available outbred strains. 
Our initial goal with this work was to combine the OR/OP model 
with established approaches for studying the loss of ovarian func-
tion and mammary tumors to develop paradigm for examining 
the impact of obesity on postmenopausal breast cancer. In addi-
tion to our intended use, this model has applicability to the study 
of numerous obesity-associated comorbidities in females.
We used the same source for female Wistar rats as we had 
for male rats in our previous studies: Charles River Laboratories 
(Wilmington, MA, USA). Identical to our male protocol, the 
female rats were individually housed in metabolic caging designed 
to allow for monitoring food intake while minimizing physical 
activity. Rats were fed the same HF purified diet (46% kcal fat; 
Research Diets, New Brunswick, NJ, USA; RD#12344) with free 
access to water.
In early studies with females, Hill’s group successfully 
separated female rats into OP and OR after 4 weeks on a 60% 
fat diet containing sucrose (18). In more recent studies, we have 
observed that separating females into their respective pheno-
types is more complicated when the sucrose-free, 46% fat diet 
is used. In our group’s first published study in females (38), we 
stratified the rats into tertiles using the male-specific protocol 
based on change in body weight in response to HF feeding early 
in life. However, we found body composition in the mature 
females to be more variable than in the males, such that larger 
animal could have a lean phenotype and smaller animals could 
present with a higher level of adiposity. This necessitated the use 
of a retrospective analysis to identify rats as lean, mid-weight, 
and obese based on their weight gain from ~8 to 19 weeks of 
age. A 19-week time point was chosen because this was the time 
at which weight gain began to taper off, which we interpreted to 
indicate that the animals were fully mature and likely no longer 
depositing lean body mass.
In two subsequent studies with females (39, 40), we adjusted 
our approach and ranked animals by their rate of weight gain in 
the obesogenic environment from 10 to 18 weeks of age. Using 
this criteria resulted in a clean separation into obese and lean phe-
notypes in the mature animals (studied between 20 and 30 weeks 
of age), in which obese rats had significantly higher body weight, 
FigURe 2 | Screening strategies for OP and OR phenotype in female wistar rats. Female rats were individually housed in wire bottom cages and fed a HF 
diet (46% kcal fat) for the duration of the study. Body weight and body composition were measured throughout the study and was correlated with % body fat at the 
time of OVX (maturity; 26.5 ± 0.6 weeks of age). (A) Change in body weight early in life (8.5–9.5 weeks of age) is not a strong predictor of adult adiposity, but 
(B) % body fat at 14 weeks of age does predict adult adiposity.
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body fat, and circulating triglycerides when compared to their 
lean counterparts.
Although our 8-week screening protocol generated a clean 
separation of the OP and OR phenotypes, it was far more labor 
intensive and costly than the 1-week protocol used in males, 
where the middle tertile of animals could be transferred out of 
the study early in life, rather than at 4–5 months of age. Thus, 
as part of a recent large obesity/menopause/breast cancer study 
with >300 female rats spread over three cohorts (currently 
unpublished), we measured body weight and composition at 
several time points to determine the earliest and shortest period 
of time that could be used to predict the OP and OR phenotypes 
in females with an acceptable level of accuracy. Female Wistar 
rats were individually housed and fed our standard HF diet (46% 
fat) for the duration of the study. Body weights were measured 
weekly for the duration of the study, and body composition 
measurements (qMR, EchoMRI, Houston, TX, USA) were 
performed at 9, 14, and 18 weeks of age. Body composition was 
also measured in all animals immediately prior to undergoing 
surgical ovariectomy (OVX). This occurred at an average of 
26.5 ± 0.6 weeks of age and was therefore used as a measure of 
adult adiposity for the analysis.
As shown in Figure  2A, the correlation between the % BF 
at the time of OVX and weight gained from 8.5 to 9.5 weeks of 
age was poor (r =  0.43). This improved slightly when change 
in body weight was measured over 2 weeks (8.5–10.5 weeks of 
age, r = 0.59, data not shown) and was further improved when 
extended to 8 weeks (8.5–18.5 weeks of age, r = 0.69, data not 
shown). However, these changes in body weight were still not 
as predictive of adult adiposity as the <1  week weight gain 
was in numerous studies in the males described above. Thus, 
we investigated other potential measures that could be used to 
accurately screen for the OP and OR phenotypes in females. 
Change in % BF over the various time points were measured, but 
these correlations were no better than changes in body weight 
(r =  0.35–0.63, depending on the cohort of animals and time 
points measured). However, % BF at 14 weeks of age was highly 
correlated with adult adiposity (Figure 2B; r = 0.70–0.81, depend-
ing on the cohort). These correlations appeared to be stronger 
when controlling for the age at the time OVX body composition 
was analyzed (r = 0.79–0.84). At 18 weeks of age, the correlation 
strengthened even further (r = 0.89). However, in our opinion, 
the added time and cost associated with the additional month of 
animal housing to delay the separation is likely not warranted. 
Importantly, our data indicate that % BF early in life (9 weeks of 
age in this study) is not an accurate predictor of % BF at maturity 
(r = 0.54), and approximately one-third of rats would have been 
incorrectly categorized (OR, mid, OP) if this early marker of 
body composition was used. Additional studies will be required 
to further determine if a time point between 9 and 14 weeks is 
predictive of long-term adiposity. In the meantime, our approach 
is to refrain from screening until ~14 weeks of age to identify the 
OR and OP phenotypes in females.
LeSSONS LeARNeD FROM OP/OR RATS
Preexisting Differences That May 
Contribute to Their Predisposition for 
Obesity
As previously mentioned, one limitation of an OP/OR model that 
requires stratification based on weight gain is that it is difficult to 
assess differences between OP and OR phenotypes prior to the 
dietary challenge. However, an inherent assumption that has been 
repeatedly validated by our group is that once classified as either 
OP or OR, rats remain within their respective groups for the 
remainder of the experimental protocol, suggesting that there are 
likely preexisting differences between these animals even before 
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the obesogenic challenge. Although our data on differences in 
OP/OR rats prior to a HF diet challenge are limited, one study 
did examine preexisting differences in skeletal muscle, and it 
was observed that OR rats had a significantly higher proportion 
of type I muscle fibers in the medial head of the gastrocnemius 
muscle than OP rats (muscle biopsy), suggesting that differences 
in muscle fiber composition may play a role in determining 
susceptibility to diet-induced obesity (22).
Additional knowledge in this field comes from studies by 
Levin et al. Initially, they identified Sprague-Dawley rats as being 
prone to become DIO or DR on the basis of high vs. low 24-h 
urine norepinephrine (NE) output (26). Using this approach, 
DIO-prone rats were observed to have significant reductions 
in heart, pancreas, and hypothalamic NE turnover, potentially 
indicating that differences in NE metabolism may be involved in 
the development of DIO on high energy diets (41). DIO-prone 
rats also exhibited greater arcuate nucleus NPY mRNA expres-
sion, fewer arcuate nucleus projections, leptin resistance, and 
abnormalities in serotonin turnover compared to DR-prone rats 
under pre-obese chow-fed conditions (42–45). Similarly, leptin 
receptor mRNA expression (46), counter regulatory responses to 
insulin-induced hypoglycemia (47), and central insulin signaling 
(48) have all been observed to be lower in the inbred line of DIO 
rats compared to DR rats. Collectively, these observations are 
indicative of abnormalities in hypothalamic pathways involved in 
energy homeostasis, all of which may contribute to the develop-
ment of DIO when presented with a high energy diet.
While the research focus of Levin’s group has primarily been 
the brain, we have directed our efforts toward differences in whole 
body and the periphery. Briefly, we have observed that regardless 
of gender, LF diet fed inbred lines of DIO and DR rats do not dif-
fer with respect to total energy expenditure (TEE), food intake, or 
physical activity (49). Others have also observed no differences in 
physical activity across the DIO and DR phenotypes on chow diet 
(50). Interestingly, despite similar intakes and energy expenditure 
on the LF diet, a greater rate of lipid disappearance was observed 
in the DR rats compared to DIO rats, suggesting greater basal 
lipid oxidation in DR rats (49).
Differential Response to an 
Obesogenic Diet
In general, following provision of a HF diet, both OP and OR 
rats initially experience a positive energy imbalance. The OR rats, 
however, appear to sense the nutrient overload and adjust their 
food intake and increase their energy expenditure to reestablish 
energy balance. In doing so, OR rats exhibit an increase in the 
oxidation of dietary fat. In contrast, OP rodents continue to eat to 
excess until expenditure increases from their accumulated mass 
to reestablish energy balance. Although OP rats have a markedly 
higher food intake, greater intake explains some, but not all of the 
variance in body weight gain between the OP and OR phenotypes 
(18, 51). These differences in food intake suggest that there are 
preexisting differences in regions of the brain that regulate feed-
ing behavior. The findings from Levin’s group with respect to 
these neuronal differences are beyond the scope of this review; 
however, we will briefly summarize some of their key findings. 
One week of HF feeding results in OP rats having elevated leptin, 
insulin, triglycerides, and glucose, along with increased lipopro-
tein lipase activity (LPL) in adipose tissue and galanin expression 
in the paraventricular nucleus (30, 49, 51). It is also noteworthy 
that OP rats have lower skeletal muscle LPL activity and a decline 
in the ratio of beta-hydroxyacyl-CoA dehydrogenase to citrate 
synthase activity, indicating a rapid decline in the capacity for 
lipid transport and the muscle to metabolize lipids (30, 52). OP 
rats are also characterized by a preferential trafficking of dietary 
lipid to adipose tissue for storage, whereas OR rats have greater 
trafficking of dietary lipid to skeletal muscle after 1 week of HF 
feeding (52). After 4–5 weeks of HF feeding, OP rats continue to 
consume more than OR rats, have a higher 24-h respiratory quo-
tient (RQ) (indicating lower relative fat oxidation), and higher 
plasma levels of free fatty acids (FFA) (18). Insulin sensitivity is 
also lower in OP rats, which is the result of both lower glucose 
uptake and lower glucose disposal in skeletal muscle (18, 23). 
Although we have observed no differences in spontaneous physi-
cal activity (SPA) following 1 week of HF feeding (49), others have 
shown that DIO rats have lower SPA after both 4 and 10 weeks on 
a HF diet, findings that have been linked to the function or orexin 
signaling (50, 53, 54).
established Obesity – Differences between 
DiO and DR Rats
Once obesity has been established and the rate of weight gain 
declines, there are concomitant reductions in the differences in 
RQ and the measured energy imbalance between DIO and DR 
rats (51). Coincident, or possibly the cause of the normalization 
of energy and nutrient balances, is the finding that many hypo-
thalamic differences/abnormalities are also normalized between 
DIO and DR rats (44). Regardless, DIO rats generated from the 
aforementioned screening protocol exhibit many of the meta-
bolic derangements and hallmarks that are linked to obesity in 
humans, including insulin resistance, glucose intolerance, lower 
spontaneous physically activity, and impaired fat oxidation (40, 
49, 52, 55, 56).
DiO/DR Differences Unique to Females
Aside from the initial studies that showed no difference in EI, 
TEE, or activity levels between DIO and DR rats, our work 
with the female-specific aspect of this model has not specifi-
cally addressed the differences between male and female rats in 
terms of their propensity to become obese. We have, however, 
performed comprehensive metabolic studies of the mature 
lean and obese animals across the estrous cycle, and during the 
initial stages of weight gain following surgical OVX (40). We 
observed that obese animals experienced greater fluctuations 
in energy balance across the 4-day estrous cycle than their 
lean counterparts, and this was driven by greater variability in 
food intake across the cycle (Figure 3). A rise in estrogen levels 
during the proestrus phase of the cycle underlies a reduction in 
food intake, and this estrogen-mediated response appears to be 
delayed in obese animals (Figure 3). While circulating estradiol 
levels were not significantly different between the DIO and DR 
animals, we suspect that the inherent impairment in leptin and/
or insulin sensitivity in the obese may impart reduced sensitivity 
to the effects of estrogen at this stage of their cycle. Additional 
FigURe 3 | energy balance across the estrous cycle and following 
OvX in lean and obese rats. Energy balance (intake – expenditure) was 
measured in lean and obese rats during each phase of the estrous cycle 
[diestrus 1 (D1), diestrus 2 (D2), proestrus (P), and estrus (E)], immediately 
following surgical ovariectomy (OVX) while in energy balance (OVX-EB), and 
during OVX-induced rapid weight gain (OVX-Gain). Relative circulating 
estrogen levels across the cycle (D1–E) and corresponding follicular and 
luteal phases of the human menstrual cycle are indicated. Obese rats 
experience greater fluctuations in energy balance across the cycle compared 
to lean rats. A rise in circulating estrogens is associated with a decrease in 
food intake (and energy balance) in the lean; however, this response is 
delayed in the obese. *Significant difference between lean and obese groups 
(P < 0.05). Modified from Ref. (40).
FigURe 4 | Rodent paradigm to study the metabolic propensity to 
regain weight after weight loss. This paradigm, employing obesity-prone 
rats, has well-defined primary and secondary outcomes that describe the 
metabolic propensity to regain weight after prolonged weight reduction. This 
approach can be applied to test weight reduction strategies for their ability to 
overcome the metabolic pressures driving weight regain by modifying the 
environmental conditions in the treatment phase and examining the response 
during the relapse phase.
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studies are needed to examine this possibility. We further found 
that cycling obese rats were less active, expended more energy 
per movement, and oxidized more carbohydrate than lean rats. 
Despite these phenotypic differences across the cycle, OVX 
induced a large positive energy imbalance in both obese and lean 
rats, which resulted primarily from an increase in energy intake 
in both groups. TEE was not altered in either group, despite the 
fact that they were eating more food. Our interpretation of these 
observations is that the increased thermic effect of food (from the 
greater food intake) is essentially balanced out by any reduction 
in the non-resting energy expenditure (NREE) that occurs from 
the decline in physical activity levels.
Characterizing the Metabolic Propensity 
to Regain weight after weight Loss
Over the past decade, we have employed the OR/OP model to 
study the phenomenon of weight regain after weight loss. The 
paradigm we developed to model the human condition is shown 
in Figure 4. Following the standardized screen to identify the OR 
and OP phenotypes described above, the young rats are main-
tained in the obesogenic environment (HF diet; limited physical 
activity) for 16 weeks, during which excessive weight gain occurs 
in what would be equivalent to childhood and adolescence. As the 
rats mature, growth rates slow, the gain in body weight and fat-free 
mass plateaus, and further weight gain comes slowly and primar-
ily in the form of fat mass. The rats are then given a two-step treat-
ment regimen (weight loss followed by weight maintenance) that 
reflects the most common approach used in humans: restricted 
consumption of an LF diet. The rats are fed a calorie-restricted 
LF diet that induces a 10–15% loss in weight that is primarily fat 
mass. A LF provision, adjusted on a daily basis, is given so that 
weight is maintained at this reduced level. In some studies, weight 
reduction has been sustained with intake-regulated maintenance 
for up to 16 weeks, a period of time that would reflect several 
years of weight reduction in humans (57). The propensity to 
regain weight is then characterized by allowing the rats to have 
free access to a specific diet while monitoring body weight, body 
composition, and pertinent aspects of metabolism as they relapse 
to the obese state. Our assertion is that this paradigm reflects the 
human condition with respect to:
(1) Genetic pressures – polygenic predisposition to become 
obese under obesogenic conditions;
(2) Obesogenic conditions during formative development – 
maturation in an obesogenic environment;
(3) The most common approach to weight reduction – restricted/
controlled intake of an LF diet; and
(4) The most common failure – not controlling intake.
In our first set of studies, we examined weight regain 
immediately after weight reduction and assessed how energy 
balance and fuel utilization were altered with prolonged 
weight reduction. As expected, the drive to regain could be 
described by an increased rate of gain and a return to the 
previous level of body weight and fat mass. We observed 
that prolonged (8-week) weight reduction was accompanied 
by a persistent reduction in TEE that was due in part to a 
sustained reduction in resting energy expenditure (REE). 
FigURe 5 | Drive to regain weight increases with time and is higher 
early in the relapse period. (A) Rats in the paradigm examining the length 
of time in weight maintenance vs. the drive to regain weight. Obesity-prone 
(OP) rats were maintained on a HF diet for 16 weeks to induce obesity. Rats 
were calorically restricted on an LF diet to induce 10–15% loss, maintained at 
this reduced weight for 0, 8, or 16 weeks, then allowed to relapse with free 
access to LF diet. (B) The rate of weight regain shown by time in 
maintenance at various times during the relapse period. The rate of weight 
regain for relapsed-obese rats is represented as the average for the first 
week, the second week, and the final 4 weeks of the relapse period. Data are 
expressed as means ± SE. With each time period, groups with the same 
letter designation are not significantly different. Modified from Ref. (34).
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By adjusting for the variability attributed to variations in 
fat-free mass, we observed an enhancement in metabolic 
efficiency, meaning the suppression in resting metabolic rate 
was greater than what would be predicted based the decreased 
mass of metabolically active tissues that occurred with weight 
reduction. Like adult humans that are obese, fluctuations in 
weight were primarily due to changes in fat mass rather than 
changes in fat-free mass. Furthermore, relapsing rats had a 
tendency to burn carbohydrate rather than fat. Importantly, 
this study established the weight loss/weight regain paradigm, 
describing the basic approach and technical tools used for its 
application (34).
The Role of Timing in the weight Regain 
Process
Length of Time in Weight Maintenance
Based upon observations from the National Weight Control 
Registry, the paradigm was applied to address whether increas-
ing the time of weight maintenance would attenuate the 
metabolic drive to regain weight. Given the sustained reduction 
in TEE with prolonged weight reduction in our prospective 
study, we were not overly optimistic that this would be the 
case. To better understand the aspects of metabolism promoting 
regain, we performed a large cross sectional study in male rats 
examining the weight reduced state at 0, 8, and 16  weeks of 
weight maintenance, before and after 8  weeks of relapse (34). 
The time in weight maintenance was equivocal to a weight-
reduced human keeping the weight off for ~10  years (57). A 
portion of these data is shown in Figure 5. We observed that 
the rate of regain increased with time in weight maintenance 
(Figure 5A), but the level of defended body weight and adiposity 
was drifting higher (obese rats switched to LF diet, dotted line). 
The animals were defending a target weight that was drifting 
upwards while they were weight reduced, an effect we attribute 
to age. Regardless, the increased rate of regain indicated that the 
metabolic pressures driving regain were greater as the time in 
weight maintenance increased. This effect on the rate of regain 
was most profound in the first week of the relapse period 
(Figure 5B). In addition, we observed that the decreased TEE 
and enhanced metabolic efficiency observed in our previous 
study remained unchanged when the length of time in weight 
maintenance increased. These metabolic adaptations that are 
thought to be contributing to the biological drive to regain 
weight did not resolve, even with long-term weight loss main-
tenance. While some similar mechanisms are likely to underlie 
the biological drive to regain weight in females, we know that 
there are many sex-specific differences that also likely exist. 
Our lab is currently performing these same studies in females 
to fully characterize the nature and extent of these differences, 
particularly with respect to (a) the extent and kinetics of the 
weight regain process and (b) the effects of menopause/loss of 
ovarian hormones on this process.
Prospective Analysis of Early Relapse
To examine this critical early period, energy balance, fuel utiliza-
tion, and regain were monitored prospectively through the first 
2 weeks of relapse. During this time, almost half of the lost weight 
had been regained (34). We observed that both an increase in 
drive to eat and a decrease in expenditure contributed to the large 
energy gap, and neither side of the energy balance equation had 
normalized by the end of 2 weeks. Enhanced metabolic efficiency 
persisted throughout this early period of relapse and contributed 
to the suppressed TEE. In other studies, we utilized nutrient trac-
ers in combination with metabolic phenotyping to examine fuel 
trafficking during the early stages of weight regain (58). During 
weight regain, we observed that the oxidation of dietary fat was 
FigURe 6 | Prospective analysis of the energy gap during weight 
regain with and without exercise. Energy balance [energy intake – total 
energy expenditure (EI-TEE)] is shown for obese, weight reduced, and 
relapsing rats either with (EX) or without (SED) treadmill exercise for several 
time periods during relapse. During weight regain, the energy gap (energy 
imbalance) resolves gradually as body weight is gained. Further, exercise 
reduces the energy gap both by suppressing EI and increasing TEE. 
*Significant difference between SED and EX rats during that time period, 
P < 0.05. Modified from Ref. (55).
FigURe 7 | Propensity to regain weight following weight loss: 
summary of data from a meta-analysis of US weight loss studies. The 
percentage of lost weight that is regained over a 5-year period according to a 
meta-analysis of 29 human weight loss studies. Adapted from Ref. (61).
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substantially suppressed and that ingested fat was preferentially 
trafficked to adipose tissue for storage. Accompanying this 
shift in metabolism early in relapse was an increased number 
of small adipocytes, which would presumably provide an ideal 
receptacle for the excess ingested energy. When taken together, 
observation of DIO rats in this paradigm of weight regain suggest 
that adaptive changes in muscle and adipose tissue establish a 
metabolic context for rapid, energetically efficient weight regain. 
In subsequent studies, we have observed how regular exercise 
counters this metabolic drive to regain weight early in relapse; 
exercise decreases the energy imbalance or energy gap (Figure 6) 
both by reducing appetite and by increasing the level of expended 
energy during weight regain (55). Using nutrient tracers, we 
provided evidence suggesting that regular exercise increases the 
oxidation of dietary fat and traffics excess energy through more 
expensive pathways of deposition (59, 60). We have examined the 
tissue-specific mechanisms of these beneficial effects of exercise 
in both skeletal muscle (59) and adipose (60), and our analysis of 
the effects in liver will be forthcoming.
Prospective Analysis of Complete Relapse
Our studies of DIO rats in this weight regain paradigm have also 
examined the later stages of the relapse process to provide a more 
complete biological picture of weight regain after weight loss. 
We were interested in following the resolution of the energy gap, 
non-protein RQ, fuel utilization, and the energetic efficiency of 
weight regain. The pattern of regain in our rat paradigm reflected 
the pattern of regain in a meta-analysis of a large number of 
human regain studies (61), which some have suggested reflects 
a first-order relationship in the resolution of this biological drive 
(Figure 7). Our observations extended our previous findings by 
showing that the enhanced metabolic efficiency and suppressed 
TEE persist throughout the process of relapse. Both increased 
intake and suppressed expenditure led to a large energy imbal-
ance, or energy gap, which resolves gradually as the weight returns 
(Figure 7). While intake returns to levels observed before weight 
loss, TEE and REE never completely resolved even after the rats 
had returned to their previous weight. Both the reduction in feed 
efficiency and the elevation in non-protein RQ declined after week 
2, suggesting that this efficient weight gain and shift in fuel use 
was most profound early in relapse when much of the lost weight 
returns (56). As expected, we and others have observed, at least in 
males, that exercise and physical activity attenuates the biological 
drive to regain weight early in relapse and leads to a lower body 
weight and fat mass (55, 59, 60). These studies support the notion 
that in males, exercise attenuates the drive to eat and increases 
expended energy above and beyond the additional energetic cost 
of the exercise bout, and that these effects persist throughout the 
entire relapse process. However, we have also observed that these 
beneficial effects of exercise may be greatly diminished if weight 
regain occurs on an obesogenic diet (62).
Use of DIO/DR Rats for Studying Obesity 
Therapeutics
To date, we have used the DIO/DR rats to develop a broad picture 
of the biological drive to regain weight after weight loss, and we 
have used the experimental paradigm of weight regain in DIO 
rats to examine the impact of one of the most effective strategies 
for weight loss maintenance: regular physical activity. Given the 
importance of the biological adaptations in driving the weight 
regain process (2), we assert that the use of this model in this 
paradigm may provide valuable information about specific 
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therapeutic strategies or combinations of strategies that are 
designed to attenuate the biological drive to regain weight after 
weight loss. In addition, our data suggest that it is critical to 
assess the sex-specific differences in the biological drive to regain 
weight, as well as the sex-specific differences in the efficacy of 
therapeutics and strategies targeting these biological adaptations 
for weight loss maintenance. The development of a more effec-
tive screening process for females discussed earlier will greatly 
facilitate this important work moving forward.
DiO/DR Studies in Females
Obesity and the Loss of Ovarian Function
As previously stated, we have applied the DIO/DR model to 
study the effects of obesity on energy homeostasis in females 
(40). By merging the DIO/DR model with other common 
approaches used in preclinical research, we have extended the 
utility of the DIO model for studies of menopause and breast 
cancer. Menopause is a very complex transition accompanied by 
a wide array of metabolic derangements in numerous tissues of 
the body. While there are several groups that have performed 
elaborate clinical studies either across the natural menopause 
transition (63) or in studies of ovarian hormone suppression 
(64–66), it is generally difficult to study the menopause transi-
tion in women because of the wide variations in the length of 
time for this transition, the variable age of onset, and the fact 
that it is generally only identified retrospectively. To overcome 
these logistical challenges in preclinical studies, we have utilized 
surgical OVX to mimic the loss of ovarian function (38, 40, 67, 
68). This approach reflects some of the metabolic consequences 
of the menopausal transition, but it has the added advantage of 
a clear demarcation of the loss of ovarian hormone production 
for precise timing for follow-up analyses. We have specifically 
merged the DIO/DR model with this surgical intervention to 
study the impact of preexisting obesity on the loss of ovarian 
hormone production. Following OVX, we have shown that both 
DIO (obese) and DR (lean) rats exhibit a 3- to 4-week period 
of rapid weight gain that is accompanied by increased energy 
intake and reduced SPA levels (38, 40). While DIO and DR 
rats generally gain the same amount of weight, the weight gain 
appears to be somewhat slower or delayed in the DIO females 
(38). While activity levels are reduced after OVX in our model, 
our data suggest that in this paradigm, weight gain is primarily 
a result of increased food intake, rather than changes in energy 
expenditure (40).
Obesity and Postmenopausal Breast Cancer
One of the many comorbidities associated with overweight 
and obesity is an increased risk for, and mortality from, many 
cancers including breast cancer (69–72). Surprisingly, obesity’s 
impact on breast cancer prior to menopause is relatively modest 
and in some cases has even been shown to be protective (73). 
After menopause, however, obesity increases the incidence, 
progression, and eventual mortality from breast cancer by up 
to 40% compared to women at a healthy weight (74). The risk is 
highest in women with a history of weight gain throughout life, 
suggesting that a crisis in obesity-driven breast cancer is likely 
to occur with the current generation of youth, where obesity 
rates are approaching an unprecedented 20% (75). Despite the 
known link between obesity and postmenopausal breast can-
cer, the mechanisms underlying this association are not fully 
understood. This represents a significant gap in our knowledge, 
and identifying mechanisms of risk and targets for intervention 
is critical.
To pursue a deeper understanding of the biological aspects 
underlying this relationship, we merged the DIO–DR/OVX 
model with a common preclinical approach to studying 
mammary tumor biology. Prior to the OP/OR screening, a 
chemical carcinogen (MNU) is delivered during mammary 
gland development. The animals are then matured under obe-
sogenic conditions into DIO and DR rats, after which they are 
subjected to surgical OVX. Merging the models in this fashion 
has generated an experimental paradigm that can further our 
understanding of the impact of obesity on postmenopausal 
breast cancer.
Mammary tumors generated in these animals are reflec-
tive of the human condition with respect to the histological 
characteristics and estrogen receptor (ER) status of the tumors 
(38, 39). Further reflective of humans, the effect of obesity 
on mammary tumor incidence is minimal prior to OVX, and 
the emergence of an obesity effect occurs only after the OVX 
surgery. Specifically, in response to OVX, obese rats exhibit 
fewer tumors that regress, more tumors that progress, and 
more tumors that newly emerge (38). Of all the characteristics 
of the obese phenotype that were examined, the strongest 
relationship with tumor promotion was observed with the 
energetics of weight gain during the ~3- to 4-week period 
of rapid weight gain that followed OVX. During this time, 
both groups experienced a dramatic increase in the rate of 
weight gain. However, despite the two groups eating similar 
amounts of food, DIO rats gained less weight (p  <  0.01). 
Consequently, feed efficiency during this transient period of 
rapid gain was lower in DIO rats (p < 0.001). Feed efficiency 
during this 3-week period of rapid weight gain was inversely 
associated with the change in tumor multiplicity (r = −0.64, 
p < 0.001) and burden (r = −0.60, p < 0.001) over the entire 
post-OVX period. Rats that experienced a lower rate of weight 
gain and a lower efficiency of storing ingested fuels during 
this distinct time period after OVX also had a higher level of 
tumor progression. These observations suggest that the impact 
of OVX on energy balance and fuel utilization is different for 
DIO and DR rats in this paradigm and that this difference may 
affect the latency, survival, and growth of mammary tumors.
OVX-Induced Overfeeding – An Example of 
Metabolic Inflexibility
We subsequently performed a nutrient tracer study in DIO/DR 
rats during the early stages of OVX-induced weight gain. Tumor 
bearing DIO and DR rats were studied after OVX both while 
in energy balance, and while experiencing their natural OVX-
induced positive energy imbalance (and subsequent weight gain) 
(39). These studies were performed in a metabolic phenotyping 
system in which energy intake, expenditure, and tissue-specific 
nutrient trafficking could be carefully measured. In DR rats, the 
OVX-induced energy imbalance was accompanied by a higher 
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level of glucose uptake (3H-2-deoxyglucose) in the mammary 
gland adipose depot, and similar trends were seen in the liver, 
retroperitoneal adipose, and skeletal muscle. Overfeeding in 
this context had no effect on the glucose uptake in the tumors 
of DR rats. Our observations in DIO rats were in direct contrast 
to those in DR rats. Glucose uptake was unaffected by the OVX-
induced positive energy imbalance in all tissues of the DIO 
rats, with the exception of the tumors, where glucose uptake 
was increased. Changes in whole body fuel utilization (RER) 
and dietary fat oxidation in response to this caloric excess also 
tended to be blunted in the obese. Taken together, our studies 
of this critical period of OVX-induced overfeeding indicate 
that DIO rats have an inability to clear and store nutrients in 
peripheral tissues, but excess nutrients are readily taken-up by 
mammary tumors.
We have interpreted these observations from the perspec-
tive of metabolic flexibility, which we broadly define as the 
ability to change or adjust nutrient metabolism in response 
to a metabolic challenge. The challenge in this context is 
OVX-induced overfeeding. In the insulin-resistant DIO rats, 
their peripheral tissues exhibit a blunted or impaired response 
to the excess energy, while their tumors readily take up the 
excess energy. In the DR rats, their peripheral tissues exhibit 
greater flexibility in their response to the challenge and are 
more capable of clearing and metabolizing the excess energy. We 
would assert that this impaired ability to respond to metabolic 
stress may underlie many of the metabolic derangements and 
accompanying pathologies associated with obesity. Even so, 
metabolic flexibility is a concept that is difficult to specifically 
define and even harder to study. The DIO/DR model may prove 
a useful tool to study this important concept in well-defined 
metabolic contexts.
CONCLUSiON
Over the past two decades, the impact of obesity on overall health 
and wellness has emerged as a major crisis. The study of OP/OR 
and the DIO/DR rat model has proven to be a valuable tool in 
translating basic science studies of energy balance and body 
weight regulation to the human condition and in furthering 
our understanding of the physiologically relevant condition of 
obesity. The strengths of this approach are the polygenic nature 
of the adipose disposition, and that it has been shown to reflect 
the human condition in a number of ways. The Levin model of 
inbred lines has been particularly useful in that they have been 
used to study OP and OR phenotypes prior to and during the 
development of a particular adiposity phenotype. While the 
commercial availability of Levin’s valuable model continues to 
be questionable, researchers may continue to pursue the OP/
OR selection of outbred strains to produce the DIO/DR pheno-
types to further our understanding of obesity and its metabolic 
complications. Both the inbred and outbred strains have proven 
extremely valuable for obesity studies of female physiology and 
have elucidated critical sex-specific differences of obesity and its 
metabolic complications.
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